Do not use any product from Gram Peptides for: Self-injection or oral use Treatment of any disease or condition Diagnostic or therapeutic purposes Cosmetic or dietary supplementation It is the sole responsibility of the purchaser to ensure compliance with all local, state, and federal laws
This leads to improved relationships, deeper understanding of clients needs, and increased trust
up to 6 treatments spaced at least 1 month apart
References: Gwyer, D., Wragg, N
Retatrutide is not currently approved by UK regulators, so it is not available on the NHS at this time
Cagrilintide works at microgram-level potency (2.4 mg maintenance), while retatrutide requires milligram-level doses up to 12 mg